Neurotype Inc.

Minneapolis, United States

Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback

$329K raised

Sep 2023

Seed

Health Care Information Technology Medical Device Neuroscience Software

Top Investors

National Institutes of HealthYale UniversityNational Institute on Drug Abuse (NIDA)Minnesota Department of Employment and Economic Development

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neurotype Inc.

How much funding has Neurotype Inc. raised?

Neurotype Inc. has raised $329K in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are Neurotype Inc.'s investors?

Neurotype Inc.'s investors include National Institutes of Health, Yale University, National Institute on Drug Abuse (NIDA), Minnesota Department of Employment and Economic Development.

Where is Neurotype Inc. headquartered?

Neurotype Inc. is headquartered in Minneapolis, United States.

What does Neurotype Inc. do?

Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback

What stage is Neurotype Inc. at?

Neurotype Inc. is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 30, 2023.

MLA

"Neurotype Inc. — Funding & Investors." VCBacked, September 30, 2023, https://www.vcbacked.co/company/neurotype-inc. Accessed June 4, 2026.

APA

VCBacked. (2023). Neurotype Inc. — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/neurotype-inc

Wikipedia (cite web)

{{cite web |title=Neurotype Inc. — Funding & Investors |url=https://www.vcbacked.co/company/neurotype-inc |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 30, 2023.